LXRX
Price
$0.77
Change
+$0.05 (+6.94%)
Updated
Jun 6 closing price
Capitalization
261.38M
53 days until earnings call
TECH
Price
$48.69
Change
+$0.38 (+0.79%)
Updated
Jun 6 closing price
Capitalization
7.57B
65 days until earnings call
Interact to see
Advertisement

LXRX vs TECH

Header iconLXRX vs TECH Comparison
Open Charts LXRX vs TECHBanner chart's image
Lexicon Pharmaceuticals
Price$0.77
Change+$0.05 (+6.94%)
Volume$6.26M
Capitalization261.38M
Bio-Techne
Price$48.69
Change+$0.38 (+0.79%)
Volume$1.19M
Capitalization7.57B
LXRX vs TECH Comparison Chart
Loading...
LXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TECH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LXRX vs. TECH commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LXRX is a Buy and TECH is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 08, 2025
Stock price -- (LXRX: $0.70 vs. TECH: $47.93)
Brand notoriety: LXRX and TECH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LXRX: 22% vs. TECH: 123%
Market capitalization -- LXRX: $261.38M vs. TECH: $7.57B
LXRX [@Biotechnology] is valued at $261.38M. TECH’s [@Biotechnology] market capitalization is $7.57B. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LXRX’s FA Score shows that 1 FA rating(s) are green whileTECH’s FA Score has 1 green FA rating(s).

  • LXRX’s FA Score: 1 green, 4 red.
  • TECH’s FA Score: 1 green, 4 red.
According to our system of comparison, TECH is a better buy in the long-term than LXRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LXRX’s TA Score shows that 5 TA indicator(s) are bullish while TECH’s TA Score has 4 bullish TA indicator(s).

  • LXRX’s TA Score: 5 bullish, 3 bearish.
  • TECH’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, LXRX is a better buy in the short-term than TECH.

Price Growth

LXRX (@Biotechnology) experienced а +13.98% price change this week, while TECH (@Biotechnology) price change was +2.72% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

LXRX is expected to report earnings on Jul 31, 2025.

TECH is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TECH($7.57B) has a higher market cap than LXRX($261M). LXRX YTD gains are higher at: -5.295 vs. TECH (-33.270). LXRX has less debt than TECH: LXRX (108M) vs TECH (395M).
LXRXTECHLXRX / TECH
Capitalization261M7.57B3%
EBITDA-184.29MN/A-
Gain YTD-5.295-33.27016%
P/E RatioN/A58.17-
Revenue31.1MN/A-
Total Cash238MN/A-
Total Debt108M395M27%
FUNDAMENTALS RATINGS
LXRX vs TECH: Fundamental Ratings
LXRX
TECH
OUTLOOK RATING
1..100
1116
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
3
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9977
PRICE GROWTH RATING
1..100
7965
P/E GROWTH RATING
1..100
1864
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECH's Valuation (3) in the Biotechnology industry is somewhat better than the same rating for LXRX (56). This means that TECH’s stock grew somewhat faster than LXRX’s over the last 12 months.

TECH's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as LXRX (100). This means that TECH’s stock grew similarly to LXRX’s over the last 12 months.

TECH's SMR Rating (77) in the Biotechnology industry is in the same range as LXRX (99). This means that TECH’s stock grew similarly to LXRX’s over the last 12 months.

TECH's Price Growth Rating (65) in the Biotechnology industry is in the same range as LXRX (79). This means that TECH’s stock grew similarly to LXRX’s over the last 12 months.

LXRX's P/E Growth Rating (18) in the Biotechnology industry is somewhat better than the same rating for TECH (64). This means that LXRX’s stock grew somewhat faster than TECH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LXRXTECH
RSI
ODDS (%)
Bearish Trend 12 days ago
74%
N/A
Stochastic
ODDS (%)
Bearish Trend 12 days ago
83%
Bullish Trend 12 days ago
70%
Momentum
ODDS (%)
Bullish Trend 12 days ago
76%
Bearish Trend 12 days ago
62%
MACD
ODDS (%)
Bullish Trend 12 days ago
80%
Bullish Trend 12 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 12 days ago
82%
Bearish Trend 12 days ago
69%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
71%
Advances
ODDS (%)
Bullish Trend 12 days ago
83%
Bullish Trend 13 days ago
70%
Declines
ODDS (%)
Bearish Trend 25 days ago
88%
Bearish Trend 26 days ago
72%
BollingerBands
ODDS (%)
Bullish Trend 12 days ago
88%
Bearish Trend 12 days ago
68%
Aroon
ODDS (%)
Bullish Trend 12 days ago
74%
Bullish Trend 12 days ago
58%
View a ticker or compare two or three
Interact to see
Advertisement
LXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TECH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

LXRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, LXRX has been loosely correlated with PLRX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if LXRX jumps, then PLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LXRX
1D Price
Change %
LXRX100%
+1.36%
PLRX - LXRX
41%
Loosely correlated
+5.47%
OCUL - LXRX
40%
Loosely correlated
+13.69%
ABOS - LXRX
38%
Loosely correlated
N/A
EYPT - LXRX
35%
Loosely correlated
+18.12%
TECH - LXRX
34%
Loosely correlated
-1.56%
More

TECH and

Correlation & Price change

A.I.dvisor indicates that over the last year, TECH has been loosely correlated with ADPT. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if TECH jumps, then ADPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TECH
1D Price
Change %
TECH100%
-1.56%
ADPT - TECH
48%
Loosely correlated
+0.11%
TRDA - TECH
47%
Loosely correlated
+0.91%
BEAM - TECH
47%
Loosely correlated
-0.88%
KYMR - TECH
47%
Loosely correlated
+2.35%
DNLI - TECH
46%
Loosely correlated
-1.29%
More